However, therapeutic reactivation of RUNX3 expression through epigenetic means may be insufficient to sustain RUNX3 expression as cancer progresses, as many UPS components, including E3 ligases such as MDM2 and Smurfs, are hyperactivated in cancer cells. This evidence concerns the gene RUNX3 and cancer.